Smallwood R H, Morgan D J, Mihaly G W, Smallwood R A
Victorian College of Pharmacy, Melbourne, Australia.
J Pharmacokinet Biopharm. 1988 Aug;16(4):397-411. doi: 10.1007/BF01062553.
Previous studies of the hepatic uptake of several albumin-bound ligands, using constant and variable albumin concentrations, were interpreted as being inconsistent with the traditional mechanism of uptake, defined as an uptake rate directly proportional to unbound ligand concentration, and led to the formulation of the albumin receptor theory of hepatic uptake. Because other experimental designs have failed to confirm the albumin receptor theory, we reexamined, using the isolated perfused rat liver preparation, the traditional uptake mechanism under the conditions used in the original studies, of constant and variable albumin concentration. Livers (n = 6) were perfused in randomized sequence with 10 different solutions containing 24-14C-taurocholate in a single-pass design. Five solutions contained fixed albumin (0.1 mM) and variable taurocholate (3-48 microM) concentrations, and five maintained the taurocholate-albumin ratio fixed at 0.06; absolute concentrations of taurocholate varied from 3-48 microM, and of albumin from 0.05-0.08 mM. At constant albumin concentration in hepatic inflow, elimination rate of taurocholate was linearly related to both total (Cin) and unbound (Cin,u) taurocholate concentration in hepatic inflow, indicating first-order elimination kinetics. When taurocholate and albumin were increased in hepatic inflow in a fixed molar ratio, taurocholate uptake rate was not linearly related to Cin,u but was still consistent with the traditional uptake mechanism. Moreover, the apparent saturation of taurocholate uptake by added albumin was consistent with the reduction in unbound fraction (fu) in accordance with the traditional uptake mechanism. This study shows that although the traditional uptake mechanism dictates that ligand uptake rate is linearly related to unbound ligand concentration within the liver, uptake rate need not necessarily be linearly related to Cin,u. Therefore, experiments in which lack of a linear relationship between uptake rate and Cin,u is found do not necessarily imply receptor-mediated uptake.
以往关于几种白蛋白结合配体肝脏摄取的研究,使用恒定和可变的白蛋白浓度,其结果被解释为与传统摄取机制不一致,传统摄取机制定义为摄取速率与未结合配体浓度成正比,并导致了肝脏摄取的白蛋白受体理论的形成。由于其他实验设计未能证实白蛋白受体理论,我们使用离体灌注大鼠肝脏制备物,在原始研究中使用的恒定和可变白蛋白浓度条件下,重新审视了传统摄取机制。用10种不同溶液以单通道设计对肝脏(n = 6)进行随机灌注,这些溶液含有24-14C-牛磺胆酸盐。5种溶液含有固定的白蛋白(0.1 mM)和可变的牛磺胆酸盐(3-48 microM)浓度,另外5种溶液保持牛磺胆酸盐与白蛋白的比例固定为0.06;牛磺胆酸盐的绝对浓度在3-48 microM之间变化,白蛋白的绝对浓度在0.05-0.08 mM之间变化。在肝脏流入物中白蛋白浓度恒定的情况下,牛磺胆酸盐的消除速率与肝脏流入物中总的(Cin)和未结合的(Cin,u)牛磺胆酸盐浓度呈线性关系,表明为一级消除动力学。当牛磺胆酸盐和白蛋白以固定摩尔比在肝脏流入物中增加时,牛磺胆酸盐摄取速率与Cin,u不成线性关系,但仍与传统摄取机制一致。此外,添加白蛋白后牛磺胆酸盐摄取的明显饱和与根据传统摄取机制未结合分数(fu)的降低一致。这项研究表明,尽管传统摄取机制表明配体摄取速率与肝脏内未结合配体浓度呈线性关系,但摄取速率不一定与Cin,u呈线性关系。因此,发现摄取速率与Cin,u之间缺乏线性关系的实验不一定意味着是受体介导的摄取。